Here's a look at AdBm's noise mitigation system, which just landed the Austin-based company a significant contract with a European wind farm installer. AdBm To ...
RIDGEFIELD, Conn., Oct. 2, 2023 /PRNewswire/ -- Boehringer Ingelheim announced today that Adalimumab-adbm injection, the company's interchangeable* biosimilar to Humira ® (adalimumab), is now ...
Adalimumab-adbm injection, a biosimilar to Humira ® (adalimumab), has been made available by Boehringer Ingelheim. Adalimumab-adbm injection is an interchangeable biosimilar and can be substituted for ...
Please provide your email address to receive an email when new articles are posted on . As with the low-concentration (50 mg/mL) version of Cyltezo (adalimumab-adbm ...
RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today a ...
Please provide your email address to receive an email when new articles are posted on . In October, Boehringer Ingelheim’s adalimumab-adbm secured a landmark FDA approval as the first interchangeable ...
Boehringer Ingelheim and GoodRx, the leading prescription savings platform in the US, announced a patient affordability initiative to provide citrate-free Adalimumab-adbm, Boehringer’s biosimilar to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results